Cargando…

Genetic Alteration of p53 in Some Patients with Adult T‐Cell Leukemia

Abnormalities of p53 mRNA in adult T‐cell leukemia (ATL) were analyzed using reverse transcription‐polymerase chain reaction‐single strand conformation polymorphism analysis. Mutations were present in two of 12 ATL patients studied, but not in 3 cell lines immortalized by human T cell leukemia virus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nagai, Hirokazu, Kinoshita, Tomohiro, Imamura, Jun, Murakami, Yoshinori, Hayashi, Kenshi, Mukai, Kiyoshi, Ikeda, Shuichi, Tobinai, Kensei, Saito, Hidehiko, Shimoyama, Masanori, Kunitada, Kunitada
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918363/ https://www.ncbi.nlm.nih.gov/pubmed/1778765 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01815.x

Ejemplares similares

Novel Interleukin‐2 Dependent T‐Cell Line Derived from Adult T‐Cell Leukemia Not Associated with Human T‐Cell Leukemia Virus Type I
por: Kagami, Yoshitoyo, et al.
Publicado: (1993)

Clinical characteristics of patients with B-cell lymphoma enrolled in clinical trials for aggressive lymphoma in Japan: Japan Clinical Oncology Group - Lymphoma Study Group study – JCOG0108A
por: Kinoshita, Tomohiro, et al.
Publicado: (2021)

PRODUCTION OF PARATHYROID HORMONE‐RELATED PROTEIN IN ADULT T‐CELL LEUKEMIA CELLS
por: Honda, Satoshi, et al.
Publicado: (1988)

Multi‐step Carcinogenesis Model for Adult T‐cell Leukemia
por: Okarmoto, Takashi, et al.
Publicado: (1989)

Replication of Hepatitis C Virus in Cultured Non‐neoplastic Human Hepatocytes
por: Kato, Nobuyuki, et al.
Publicado: (1996)

Hepatic microRNA expression is associated with the response to interferon treatment of chronic hepatitis C
por: Murakami, Yoshiki, et al.
Publicado: (2010)

Cyclophilin and Viruses: Cyclophilin as a Cofactor for Viral Infection and Possible Anti-Viral Target
por: Watashi, Koichi, et al.
Publicado: (2007)

Treatment with a High Dose Combination of PMSG/hCG Preparation of Mares Clinically Diagnosed with Ovarian Quiescence during the Breeding Season (Investigation from 1975 to 2000)
por: TSUKADA, Tsutomu, et al.
Publicado: (2008)

Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2017)

Clinical development of anti‐CD19 chimeric antigen receptor T‐cell therapy for B‐cell non‐Hodgkin lymphoma
por: Makita, Shinichi, et al.
Publicado: (2017)

Hepatitis C Virus in Pelvic Lymph Nodes and Female Reproductive Organs
por: Sugiyama, Kazuo, et al.
Publicado: (1997)

Multidrug Resistance in Cultured Human Leukemia and Lymphoma Cell Lines Detected by a Monoclonal Antibody, MRK16
por: Ishida, Yasushi, et al.
Publicado: (1989)

A Novel Multidrug Resistance in Cultured Leukemia and Lymphoma Cells Detected by a Monoclonal Antibody to 85‐kDa Protein, MRK20
por: Ohtsu, Tomoko, et al.
Publicado: (1989)

A Structural Protein Encoded by the 5′ Region of the Hepatitis C Virus Genome Efficiently Detects Viral Infection
por: Kato, Nobuyuki, et al.
Publicado: (1990)

Safety and pharmacokinetics of polatuzumab vedotin in Japanese patients with relapsed/refractory B-cell non-Hodgkin lymphoma: a phase 1 dose-escalation study
por: Kinoshita, Tomohiro, et al.
Publicado: (2020)

Ick Suppresses Gene Expression from Various Promoters Including Human T‐Cell Leukemia Virus Type I Promoter
por: Ohta, Masataka, et al.
Publicado: (1990)

Hepatitis C Virus Core Protein Abrogates the DDX3 Function That Enhances IPS-1-Mediated IFN–Beta Induction
por: Oshiumi, Hiroyuki, et al.
Publicado: (2010)

Intrafollicular Concentrations of Steroid Hormones and PGF(2α) in Relation to Follicular Development in the Mares during the Breeding Season
por: TSUKADA, Tsutomu, et al.
Publicado: (2008)

The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families
por: Murakami, Yoshiki, et al.
Publicado: (2011)

Repressive Effect of the nef cDNA of Human Immunodeficiency Virus Type 1 on the Promoter Activity of the Viral Long Terminal Repeat
por: Mori, Shigehisa, et al.
Publicado: (1990)

Efficacy and safety of ibrutinib in Japanese patients with relapsed or refractory mantle cell lymphoma
por: Maruyama, Dai, et al.
Publicado: (2016)

A phase II Japanese trial of fludarabine, cyclophosphamide and rituximab for previously untreated chronic lymphocytic leukemia
por: Izutsu, Koji, et al.
Publicado: (2020)

A SOLUBLE‐FACTOR(S) SECRETED BY A HUMAN SKIN CANCER CELL LINE SUPPORTS CLONAL GROWTH OF ADULT T‐CELL LEUKEMIA CELLS
por: Kagami, Yoshitoyo, et al.
Publicado: (1988)

Clinical Trials and Treatment of ATL
por: Tsukasaki, Kunihiro, et al.
Publicado: (2012)

Safety, tolerability and pharmacokinetics of shorter duration of infusion of obinutuzumab in Japanese patients with B-cell non-Hodgkin lymphoma: final results of the phase II GATS study
por: Ohmachi, Ken, et al.
Publicado: (2018)

Phase I study of tirabrutinib (ONO‐4059/GS‐4059) in patients with relapsed or refractory B‐cell malignancies in Japan
por: Munakata, Wataru, et al.
Publicado: (2019)

Critical Role of Interferon-α Constitutively Produced in Human Hepatocytes in Response to RNA Virus Infection
por: Tsugawa, Yoji, et al.
Publicado: (2014)

Serodiagnostic Assay of Hepatitis C Virus Infection Using Viral Proteins Expressed in Escherichia coli
por: Mori, Shigehisa, et al.
Publicado: (1992)

Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation
por: Nishitsuji, Hironori, et al.
Publicado: (2022)

Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma
por: Maruyama, Dai, et al.
Publicado: (2017)

Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea
por: Ogura, Michinori, et al.
Publicado: (2020)

Massive Sero–epidemiological Survey of Hepatitis C Virus: Clustering of Carriers on the Southwest Coast of Tsushima, Japan
por: Ito, Shin‐Ichiro, et al.
Publicado: (1991)

Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251
por: Ueda, Youki, et al.
Publicado: (2018)

Virus Isolate‐specific Antibodies against Hypervariable Region 1 of the Hepatitis C Virus Second Envelope Protein, gp70
por: Kato, Nobuyuki, et al.
Publicado: (1994)

Orchestration of Intracellular Circuits by G Protein-Coupled Receptor 39 for Hepatitis B Virus Proliferation
por: Goto, Kaku, et al.
Publicado: (2020)

High‐level expression of STING restricts susceptibility to HBV by mediating type III IFN induction
por: Dansako, Hiromichi, et al.
Publicado: (2018)

Helper virus-independent trans-replication of hepatitis C virus-derived minigenome
por: Zhang, Jing, et al.
Publicado: (2007)

Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?
por: Yamamoto, Naoki, et al.
Publicado: (2021)

Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
por: Tobinai, Kensei, et al.
Publicado: (2012)

Safety and Efficacy of Brentuximab Vedotin in the Treatment of Classic Hodgkin Lymphoma
por: Makita, Shinichi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lujt7kd6qm6ordjpkcn0f20c99